LANSDOWNE PARTNERS (UK) LLP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 136 filers reported holding CYTOKINETICS INC in Q4 2018. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
LANSDOWNE PARTNERS (UK) LLP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q1 2019$11,809,000
-29.4%
1,459,706
-44.9%
0.26%
+6.1%
Q4 2018$16,735,000
-35.8%
2,647,9810.0%0.25%
-10.2%
Q3 2018$26,083,000
+18.7%
2,647,9810.0%0.28%
+31.0%
Q2 2018$21,978,000
+15.3%
2,647,9810.0%0.21%
+5.5%
Q1 2018$19,065,000
-11.7%
2,647,9810.0%0.20%0.0%
Q4 2017$21,581,000
-43.8%
2,647,9810.0%0.20%
-50.2%
Q3 2017$38,396,000
+19.8%
2,647,9810.0%0.40%
+43.4%
Q2 2017$32,041,000
+7.4%
2,647,981
+14.0%
0.28%
+7.7%
Q1 2017$29,836,000
+5.8%
2,321,8650.0%0.26%
+3.2%
Q4 2016$28,211,000
+32.4%
2,321,8650.0%0.25%
+36.4%
Q3 2016$21,315,000
-3.3%
2,321,8650.0%0.18%
-10.2%
Q2 2016$22,034,000
+34.6%
2,321,8650.0%0.20%
+58.9%
Q1 2016$16,369,000
-32.6%
2,321,8650.0%0.13%
-22.8%
Q4 2015$24,287,000
+56.4%
2,321,8650.0%0.17%
+27.5%
Q3 2015$15,533,000
-0.4%
2,321,8650.0%0.13%
-1.5%
Q2 2015$15,603,000
-0.9%
2,321,8650.0%0.13%
-6.3%
Q1 2015$15,742,000
-15.4%
2,321,8650.0%0.14%
-15.0%
Q4 2014$18,598,000
+127.6%
2,321,8650.0%0.17%
+128.8%
Q3 2014$8,173,000
-26.4%
2,321,8650.0%0.07%
-30.5%
Q2 2014$11,099,0002,321,8650.10%
Other shareholders
CYTOKINETICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$7,286,7218.83%
Saturn V Capital Management LP 406,225$13,251,0607.35%
Logos Global Management LP 1,650,000$53,823,0007.32%
Finepoint Capital LP 369,093$12,039,8144.16%
GREAT POINT PARTNERS LLC 600,000$19,572,0003.83%
Boxer Capital, LLC 2,100,000$68,5023.18%
PFM Health Sciences, LP 2,399,545$78,273,1583.04%
DAFNA Capital Management LLC 332,734$10,853,7832.97%
Integral Health Asset Management, LLC 650,000$21,203,0002.62%
Sofinnova Investments, Inc. 843,228$27,506,0971.80%
View complete list of CYTOKINETICS INC shareholders